Dennis Waalboer

Dennis Waalboer is currently employed as a Senior Scientist at Byondis since November 2019. Prior to that, Dennis held the same position at Synthon from May 2015 to November 2019. Dennis has also worked as a Post-doc at VU University Medical Center, focusing on the development of transition metal-based linker systems for antibody-drug conjugates. Furthermore, Dennis has experience as a Post-doc medicinal chemistry at The Institute of Cancer Research, where Dennis researched chemical probes for target identification studies and contributed to lead optimization of cancer therapeutics. Additionally, Dennis worked as a PhD student at Radboud University Nijmegen, specializing in the total synthesis of natural products.